Amicus Therapeutics Inc. buy Wells Fargo & Company
Start price
30.05.24
/
50%
€8.90
Target price
30.05.25
€16.62
Performance (%)
-39.89%
End price
31.05.25
€5.35
Summary
This prediction ended on 31.05.25 with a price of €5.35. Massive losses of -39.89% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -0.813% | -0.813% | 51.553% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.70
20.02.25
20.02.25
€16.27
20.02.26
20.02.26
36.78%
21.02.26
21.02.26
